China's National Medical Products Administration has approved Solasia Pharma's Episil, which is indicated to relieve oral mucositis-associated pain.
Solasia's drug for pain associated with oral mucositis OK'd in China
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.